November 2019: CBD for the Reduction of Craving and Anxiety in Heroin Use Disorder


Manage episode 245414891 series 1524664
By American Psychiatric Association Publishing and American Journal of Psychiatry. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Executive Editor Michael Roy speaks with Yasmin Hurd, Ph.D., about her research on the potential of cannabidiol (CBD) to reduce cue-induced craving and anxiety, two critical features of addiction that often contribute to relapse and continued drug use, in drug-abstinent individuals with heroin use disorder.

  • What has past research with CBD shown in terms of its function as a treatment for mental illness? [2:29]
  • Why the present study examined the potential of CBD to moderate craving and anxiety, and how these reactions were triggered among participants [4:14]
  • How did the study team decide to evaluate CBD at two different doses? [5:54]
  • Main findings of the study [7:42]
  • Discussion of secondary outcomes and adverse events [9:02]
  • Take-home messages for mental health professionals and the general public [11:37]
  • Thoughts on how the medical use of CBD will fit in to the broader trend of the relaxation of marijuana laws throughout the United States [13:28]

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online. Also visit the online edition of this month’s Journal to watch a video of Deputy Editor Daniel S. Pine, M.D., present highlights from the issue.

Follow the Journal on Twitter.

E-mail us at

158 episodes